Triglycerides measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genome-wide association study identifies novel recessive genetic variants for high TGs in an Arab population.
|
30108155 |
2018 |
Congenital leukocyte adherence deficiency
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Leukocyte adhesion deficiency II (LAD II) is a rare congenital disease which is caused by a defect in fucosylation of glycoconjugates.
|
12476046 |
2002 |
Congenital leukocyte adherence deficiency
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
These symptoms are consistent with but more severe than those reported for people with leukocyte adhesion deficiency III (LAD-III).
|
19234460 |
2009 |
Congenital leukocyte adherence deficiency
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Leukocyte adhesion deficiency-1 (LAD-1) is the result of mutations in the beta2 subunit of the CD11/CD18 integrins, LFA-1, Mac-1, p150,95 and alphadbeta2.
|
10936446 |
2000 |
Congenital leukocyte adherence deficiency
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Leukocyte adhesion deficiency 1 (LAD1) is an inherited disorder of neutrophil function.
|
21103413 |
2010 |
Congenital leukocyte adherence deficiency
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Novel integrin-dependent platelet malfunction in siblings with leukocyte adhesion deficiency-III (LAD-III) caused by a point mutation in FERMT3.
|
20216991 |
2010 |
Congenital leukocyte adherence deficiency
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Leukocyte adhesion deficiency II (LAD II) is characterized by the lack of fucosylated glycoconjugates, including selectin ligands, causing immunodeficiency and severe mental and growth retardation.
|
11326279 |
2001 |
Congenital leukocyte adherence deficiency
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Disabling mutations in integrin-mediated cell signaling have been a major focus of interest over the last decade for patients affected with leukocyte adhesion deficiency-III (LAD-III).
|
25854317 |
2015 |
Congenital leukocyte adherence deficiency
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Kindlin-3 is a key lymphocyte function-associated antigen-1 (LFA-1) coactivator deleted in leukocyte adhesion deficiency-III (LAD-III).
|
21536861 |
2011 |
Congenital leukocyte adherence deficiency
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Kindlin-3 is a novel integrin activator in hematopoietic cells, and its deficiency leads to immune problems and severe bleeding, known as leukocyte adhesion deficiency III (LAD-III).
|
22564402 |
2012 |
Congenital leukocyte adherence deficiency
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
In the disorder leukocyte adhesion deficiency III (LAD-III), integrins on platelets and leukocytes are expressed but fail to function and this leads to severe bleeding and infections at an early age.
|
20357244 |
2010 |
Congenital leukocyte adherence deficiency
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Leukocyte adhesion deficiency II (LAD II) belongs to a group of human congenital diseases in which the interactions of leukocytes with the vascular endothelium are strongly impaired.
|
16956371 |
2006 |
Congenital leukocyte adherence deficiency
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Neutrophils isolated from a child with severe leukocyte adhesion deficiency 1 (LAD1) had a complete absence of expression of the CD11/CD18 beta2 integrin family of adhesion molecules, and were shown to be deficient in the in vitro adhesion and migration properties.
|
10564719 |
2000 |
Congenital leukocyte adherence deficiency
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Leukocyte adhesion deficiency II (LAD II) is a rare congenital disease caused by defective fucosylation leading to immuno-deficiency and psychomotor retardation.
|
16455955 |
2006 |
Congenital leukocyte adherence deficiency
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Leukocyte adhesion deficiency 1 (LAD-1) is caused by defects in the β2 integrin subunit.
|
25514840 |
2015 |
Diabetes Mellitus
|
0.070 |
GeneticVariation
|
group |
BEFREE |
We previously demonstrated the presence of two different populations among adult-onset autoimmune diabetes (latent autoimmume diabetes of adults; LADA) having high or low titre of antibodies to glutamic acid decarboxylase (GADA).
|
20546291 |
2010 |
Diabetes Mellitus
|
0.070 |
GeneticVariation
|
group |
BEFREE |
In multilocus haplotype analysis, the association between frequencies of the haplotypes and AF risk was showed in AGT gene (rs7539020-rs3789678), compared 'TT' haplotype with the common 'TC' haplotype, adjusted for age, gender, LVEF, LVEDD, LAD and frequency of hypertension and diabetes.
|
25723521 |
2015 |
Diabetes
|
0.060 |
GeneticVariation
|
disease |
BEFREE |
We previously demonstrated the presence of two different populations among adult-onset autoimmune diabetes (latent autoimmume diabetes of adults; LADA) having high or low titre of antibodies to glutamic acid decarboxylase (GADA).
|
20546291 |
2010 |
Diabetes
|
0.060 |
GeneticVariation
|
disease |
BEFREE |
In multilocus haplotype analysis, the association between frequencies of the haplotypes and AF risk was showed in AGT gene (rs7539020-rs3789678), compared 'TT' haplotype with the common 'TC' haplotype, adjusted for age, gender, LVEF, LVEDD, LAD and frequency of hypertension and diabetes.
|
25723521 |
2015 |
Leukocyte adhesion deficiency type 1
|
0.050 |
GeneticVariation
|
disease |
BEFREE |
Leukocyte adhesion deficiency type 1 (LAD 1 - CD18 deficiency) is a rare disease characterized by disturbance of phagocyte function associated with less severe cellular and humoral dysfunction.
|
25106692 |
2014 |
Leukocyte adhesion deficiency type 1
|
0.050 |
GeneticVariation
|
disease |
BEFREE |
LAD I and variant LAD I syndromes are caused by mutations that impair expression or function of integrins of the beta 2 class (CD11/CD18 integrins, or "leukocyte" integrins).
|
11753075 |
2002 |
Leukocyte adhesion deficiency type 1
|
0.050 |
GeneticVariation
|
disease |
BEFREE |
Leukocyte adhesion deficiency type-1(LAD-1) is one of the immunodeficiency autosomal recessive diseases that results from mutation in integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) ITGB2 gene.
|
24338230 |
2014 |
Congenital disorder of glycosylation, type 2C
|
0.050 |
GeneticVariation
|
disease |
BEFREE |
Leukocyte adhesion deficiency type II (LAD II) is a rare genetic disease characterized by severe immunodeficiency which is related to defective expression in leukocytes of sialyl-Lewis X (SLeX), a fucosylated ligand for endothelial selectins.
|
9662431 |
1998 |
Congenital disorder of glycosylation, type 2C
|
0.050 |
GeneticVariation
|
disease |
BEFREE |
Leukocyte adhesion deficiency type II (LAD II) is caused by a disorder in the metabolism of GDP-L-fucose, which causes hypofucosylation of glycoconjugates.
|
10410995 |
1999 |
Congenital disorder of glycosylation, type 2C
|
0.050 |
GeneticVariation
|
disease |
BEFREE |
Leukocyte adhesion deficiency type II (LAD II) is a rare disorder characterized by recurrent infections, persistent leukocytosis and severe mental and growth retardation.
|
11529501 |
2001 |